Granules India Limited

Granules India Limited (GRANULES) is a mid-cap Healthcare company valued at ₹20,461 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Granules India Limited last traded at ₹810, modestly up 0.11% on the day.

Recent developments

On 2026-09-11, the promoter sold 1.72 crore shares worth Rs 1,500 crore, funding the second tranche of a preferential issue. The same day, the stock reached a 52-week high of Rs 913.8. On 2026-07-30, the company reported consolidated June 2026 net sales of Rs 1,476.77 crore, up 22.04% year-on-year.

Financial performance

The company's business is improving, with annual revenue rising 19.7% and net profit growing 18.5% year-on-year. The latest quarter saw revenue jump 22.0% and net profit surge 59.3% compared to the same quarter a year earlier, though the net profit margin slightly narrowed to 11.1% from 11.2%.

Valuation multiples

The stock trades at 33.1 times earnings, broadly in line with the Healthcare median of 32.0, 4.73 times book value. It yields 0.2%.

Things to watch

The promoter's holding fell by 0.63 percentage points in the quarter. Domestic institutional holding dropped by 0.71 percentage points. The stock is 11.0% below its 52-week high. The net profit margin narrowed slightly to 11.1%.

Where it stands

The company's latest quarter showed strong growth in both revenue and net profit, with the latter rising 59.3% year-on-year. The promoter's recent sale of shares and the stock's distance from its 52-week high are key factors to note. The stock is currently trading at ₹821.75.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.